N.G. Industries [NGIND] vs Indraprastha Medical [INDRAMEDCO] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: N.G. Industries Ltd. wins in 7 metrics, Indraprastha Medical Corporation Ltd. wins in 13 metrics, with 0 ties. Indraprastha Medical Corporation Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | N.G. Industries Ltd. | Indraprastha Medical Corporation Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.16 | 20.08 | N.G. Industries Ltd. |
| Price-to-Book Ratio | 1.19 | 5.57 | N.G. Industries Ltd. |
| Debt-to-Equity Ratio | 2.72 | 4.76 | N.G. Industries Ltd. |
| PEG Ratio | -0.11 | -5.81 | N.G. Industries Ltd. |
| EV/EBITDA | 26.03 | 12.10 | Indraprastha Medical Corporation Ltd. |
| Profit Margin (TTM) | -8.41% | 12.60% | Indraprastha Medical Corporation Ltd. |
| Operating Margin (TTM) | 8.08% | 13.64% | Indraprastha Medical Corporation Ltd. |
| EBITDA Margin (TTM) | 8.08% | 13.64% | Indraprastha Medical Corporation Ltd. |
| Return on Equity | 20.09% | 26.98% | Indraprastha Medical Corporation Ltd. |
| Return on Assets (TTM) | 18.69% | 18.90% | Indraprastha Medical Corporation Ltd. |
| Free Cash Flow (TTM) | $11.50M | $1.20B | Indraprastha Medical Corporation Ltd. |
| Dividend Yield | 4.47% | 0.95% | N.G. Industries Ltd. |
| 1-Year Return | -27.44% | -5.84% | Indraprastha Medical Corporation Ltd. |
| Price-to-Sales Ratio (TTM) | 2.83 | 2.53 | Indraprastha Medical Corporation Ltd. |
| Enterprise Value | $453.08M | $32.43B | Indraprastha Medical Corporation Ltd. |
| EV/Revenue Ratio | 2.75 | 2.23 | Indraprastha Medical Corporation Ltd. |
| Gross Profit Margin (TTM) | 72.57% | 37.00% | N.G. Industries Ltd. |
| Revenue per Share (TTM) | $49 | $158 | Indraprastha Medical Corporation Ltd. |
| Earnings per Share (Diluted) | $-4.14 | $19.94 | Indraprastha Medical Corporation Ltd. |
| Beta (Stock Volatility) | 0.15 | 0.58 | N.G. Industries Ltd. |
N.G. Industries Ltd. vs Indraprastha Medical Corporation Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| N.G. Industries Ltd. | 1.87% | 1.70% | 3.28% | -6.45% | -4.31% | -16.58% |
| Indraprastha Medical Corporation Ltd. | 0.38% | -0.95% | 4.95% | -1.44% | -21.11% | -14.34% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| N.G. Industries Ltd. | -27.44% | 33.58% | 123.69% | 58.53% | 86.14% | 161.22% |
| Indraprastha Medical Corporation Ltd. | -5.84% | 323.69% | 338.93% | 635.89% | 971.03% | 1,203.39% |
Performance & Financial Health Analysis: N.G. Industries Ltd. vs Indraprastha Medical Corporation Ltd.
| Metric | NGIND | INDRAMEDCO |
|---|---|---|
| Market Information | ||
| Market Cap | ₹435.06M | ₹37.31B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 245 | 399,153 |
| 90 Day Avg. Volume | 618 | 289,583 |
| Last Close | ₹119.75 | ₹385.95 |
| 52 Week Range | ₹111.00 - ₹168.95 | ₹342.00 - ₹640.85 |
| % from 52W High | -29.12% | -39.78% |
| All-Time High | ₹230.00 (Feb 05, 2024) | ₹640.85 (Nov 06, 2025) |
| % from All-Time High | -47.93% | -39.78% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.14% |
| Quarterly Earnings Growth | -0.94% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | -0.08% | 0.13% |
| Operating Margin (TTM) | 0.08% | 0.14% |
| Return on Equity (TTM) | 0.20% | 0.27% |
| Debt to Equity (MRQ) | 2.72 | 4.76 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹117.30 | ₹71.88 |
| Cash per Share (MRQ) | ₹7.21 | ₹50.31 |
| Operating Cash Flow (TTM) | ₹103.49M | ₹1.78B |
| Levered Free Cash Flow (TTM) | ₹77.39M | ₹1.61B |
| Dividends | ||
| Last 12-Month Dividend Yield | 4.47% | 0.95% |
| Last 12-Month Dividend | ₹7.00 | ₹4.50 |
Valuation & Enterprise Metrics Analysis: N.G. Industries Ltd. vs Indraprastha Medical Corporation Ltd.
| Metric | NGIND (Apr 24, 2026) | INDRAMEDCO (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.16 | 20.08 |
| Forward P/E | 25.70 | 18.63 |
| PEG Ratio | -0.11 | -5.81 |
| Price to Sales (TTM) | 2.83 | 2.53 |
| Price to Book (MRQ) | 1.19 | 5.57 |
| Market Capitalization | ||
| Market Capitalization | ₹435.06M | ₹37.31B |
| Enterprise Value | ₹453.08M | ₹32.43B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.75 | 2.23 |
| Enterprise to EBITDA | 26.03 | 12.10 |
| Risk & Other Metrics | ||
| Beta | 0.15 | 0.58 |
| Book Value per Share (MRQ) | ₹117.30 | ₹71.88 |
Financial Statements Comparison: N.G. Industries Ltd. vs Indraprastha Medical Corporation Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | NGIND (2025) | INDRAMEDCO (2025) |
|---|---|---|
| Revenue/Sales | 165.47M | 13.07B |
| Cost of Goods Sold | 42.84M | 8.53B |
| COGS % of Revenue | 25.9% | 65.3% |
| Gross Profit | 122.63M | 4.54B |
| Gross Margin | 74.1% | 34.7% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 12.65M | 2.10B |
| Operating Margin | 7.6% | 16.1% |
| EBITDA | 27.68M | 2.64B |
| EBITDA Margin | 16.7% | 20.2% |
| Pre-Tax Income | 91.42M | 2.16B |
| Pre-Tax Income % of Revenue | 55.2% | 16.6% |
| Income Tax | 14.02M | 553.30M |
| Income Tax % of Revenue | 8.5% | 4.2% |
| Net Income (Profit) | 77.39M | 1.61B |
| Profit Margin | 46.8% | 12.3% |
Balance Sheet & Liquidity Metrics
| Metric | NGIND (2025) | INDRAMEDCO (2025) |
|---|---|---|
| Cash & Equivalents | 23.20M | 614.80M |
| Total Current Assets | 38.33M | 4.31B |
| Total Current Assets % of Revenue | 23.2% | 33.0% |
| Total Current Liabilities | 31.04M | 1.79B |
| Total Current Liabilities % of Revenue | 18.8% | 13.7% |
| Long-Term Debt | N/A | 305.40M |
| Long-Term Debt % of Revenue | 0.0% | 2.3% |
| Total Shareholders Equity | 385.18M | 5.97B |
| Retained Earnings | 318.65M | 4.75B |
| Retained Earnings % of Revenue | 192.6% | 36.4% |
| Property, Plant & Equipment | 131.36M | 2.60B |
Cash Flow Statement Comparison
| Metric | NGIND (2025) | INDRAMEDCO (2025) |
|---|---|---|
| Operating Cash Flow | 103.49M | 1.78B |
| Operating Cash Flow % of Revenue | 62.5% | 13.6% |
| Capital Expenditures | 110,000 | -363.30M |
| Free Cash Flow | 11.50M | 1.20B |
| FCF Margin | 6.9% | 9.2% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | NGIND | INDRAMEDCO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 3.35M | 91.67M |
| Float Shares | 756,557 | 41.01M |
| % Held by Insiders | 77.37% | 55.41% |
| % Held by Institutions | 0.00% | 0.57% |
| % Held by Public | 22.63% | 44.02% |
Dividend Analysis & Yield Comparison: N.G. Industries Ltd. vs Indraprastha Medical Corporation Ltd.
| Metric | NGIND | INDRAMEDCO |
|---|---|---|
| Last 12-Month Dividend | ₹7.00 | ₹4.50 |
| Last 12-Month Dividend Yield | 4.47% | 0.95% |
| 3-Year Avg Annual Dividend | ₹3.50 | ₹4.00 |
| 3-Year Avg Dividend Yield | 2.33% | 1.26% |
| 3-Year Total Dividends | ₹10.50 | ₹12.00 |
| Ex-Dividend Date | Sep 19, 2025 | Sep 18, 2025 |